Table 2. Antimicrobial Susceptibility Testing of the Isolates a, b.
| Bacteria | SXT | TE | TMP | STR | CIP | CHL | AMP |
|---|---|---|---|---|---|---|---|
| EPEC | 28 (100) | 28 (100) | 28 (100) | 28 (100) | 28 (100) | 28 (100) | 28 (100) |
| S. entarica | 10 (27.8) | 17 (47.2) | 10 (27.8) | 17 (47.2) | 4 (11.1) | 1 (2.8) | 9 (25) |
| Sh. sonnei | 30 (93.7) | 28 (84.3) | 30 (93.7) | 13 (40.6) | 1 (3.1) | 7 (18.7) | 12 (37.5) |
| V. cholerae | 23 (95.8) | 0 (0) | 23 (95.8) | 23 (95.8) | 2 (8.3) | 22 (91.7) | 3 (12.5) |
| Total | 91 (75.8) | 73 (60.8) | 91 (75.8) | 81 (67.5) | 35 (29.2) | 58 (48.3) | 52 (43.3) |
a Abbreviations: AMP, aminoglycosides; CHL, amphenicols; CIP, fluoroquinolones; STR, ; SXT, sulfonamides; TE, tetracyclines; TMP, trimethoprim alone.
b Data are presented in No. (%).